» Articles » PMID: 33584260

Neuroprotective Studies on L. Essential Oils Using Transgenic Animal Models

Overview
Journal Front Pharmacol
Date 2021 Feb 15
PMID 33584260
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

L. and related species are reported to possess neuroprotective potentials. In an attempt to validate its anti-Alzheimer's potentials, leaf oils (Ph. Lo) were extensively evaluated in this study against several and models of Alzheimer's disease. The Ph. Lo were tested against pathological targets of Alzheimer's diseases (ADs). The and assays were done for cholinesterase inhibition, anti-radical properties and cognitive assessments using transgenic animal models. In preliminary cholinesterase inhibition assays, Ph. Lo were more active against acetylcholinesterase (AChE), butyrylcholinesterase (BChE), 1,1-diphenyl-2-picrylhydrazyl (DPPH), 2,2-azinobis (3-ethylbenzthiazoline)-6-sulfonic acid (ABTS), and hydrogen peroxide (HO) radicals. Subsequently, Ph. Lo was evaluated for its effects on special memory, exploratory behavior, and coordination using shallow water maze (SWM), Y-maze, open filed, and balance beam tests. Animal pre-genotyping was done polymerase chain reaction (PCR) to confirm amyloid precursor protein (APP) transgene, and after completion of drug therapy, brain homogenates from the cortex and hippocampus were evaluated for cholinesterase and free radical studies. In SWM task, disease control animals treated with 10 mg/kg of Ph. Lo for 5 days exhibited significant improvement in cognitive performance indicated by low escape times on 5th day compared with normal animals. In the Y-maze test, transgenic animals showed higher spontaneous alternation behavior than disease control animals and standard control group animals. Ph. Lo therapy has improved the exploratory behavior and declined anxiety behavior in diseased animals as accessed open field test. Ph. Lo administration significantly augmented the motor and coordination abilities of transgenic animals when compared to other groups of animals and declined AChE, BChE activities as well as free radicals load in the cortex and hippocampus tissues. Based on our finding, it is concluded that Ph. Lo exhibit significant neuroprotective potentials preliminary due to their anti-radicals and cholinesterase inhibitory activities. Ph. Lo need further detailed studies as potential aromatherapy against neurodegenerative disorders.

Citing Articles

Appraisal of the Neuroprotective Potentials of Isoeugenol Using and Approaches.

Alyami B, Ahmad Z, Ghufran M, Mahnashi M, Sadiq A, Ayaz M Curr Neuropharmacol. 2025; 23(3):317-328.

PMID: 39989009 PMC: 11808583. DOI: 10.2174/1570159X22666240329125626.


New Perspectives on the Old Uses of Traditional Medicinal and Edible Herbs: Extract and Spent Material of (L.) Delarbre.

Jovanovic M, Vunduk J, Mitic-Culafic D, Svircev E, Vojvodic P, Tomic N Nutrients. 2024; 16(19).

PMID: 39408335 PMC: 11478433. DOI: 10.3390/nu16193368.


Phytochemical analysis, radical scavenging and glioblastoma U87 cells toxicity studies of stem bark of buckthorn (Rhamnus pentapomica R. Parker).

Rehman Y, Iqbal A, Ali G, Alotaibi G, Ahmed A, Ayaz M BMC Complement Med Ther. 2024; 24(1):12.

PMID: 38167318 PMC: 10759440. DOI: 10.1186/s12906-023-04309-w.


Inhibitory effects of L. essential oil on lipopolysaccharide-induced microglia activation-integrated characteristic analysis of volatile compounds, network pharmacology, and BV-2 cell.

Lu J, Zeng X, Feng Y, Li S, Wang Y, Liu Y Front Pharmacol. 2023; 14:1180618.

PMID: 37601063 PMC: 10436289. DOI: 10.3389/fphar.2023.1180618.


Neuroprotection of Kaji-Ichigoside F1 via the BDNF/Akt/mTOR Signaling Pathways against NMDA-Induced Neurotoxicity.

Chen F, Wang L, Jin F, Li L, Wang T, Gao M Int J Mol Sci. 2022; 23(24).

PMID: 36555790 PMC: 9785992. DOI: 10.3390/ijms232416150.


References
1.
Scuteri D, Morrone L, Rombola L, Avato P, Bilia A, Corasaniti M . Aromatherapy and Aromatic Plants for the Treatment of Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer's Disease: Clinical Evidence and Possible Mechanisms. Evid Based Complement Alternat Med. 2017; 2017:9416305. PMC: 5390566. DOI: 10.1155/2017/9416305. View

2.
Ayaz M, Sadiq A, Junaid M, Ullah F, Ovais M, Ullah I . Flavonoids as Prospective Neuroprotectants and Their Therapeutic Propensity in Aging Associated Neurological Disorders. Front Aging Neurosci. 2019; 11:155. PMC: 6606780. DOI: 10.3389/fnagi.2019.00155. View

3.
Ono K, Hasegawa K, Naiki H, Yamada M . Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. J Neurosci Res. 2004; 75(6):742-50. DOI: 10.1002/jnr.20025. View

4.
Imran M, Ullah F, Ayaz M, Sadiq A, Raza Shah M, Jan M . Anticholinesterase and antioxidant potentials of Nonea micrantha Bioss. & Reut along with GC-MS analysis. BMC Complement Altern Med. 2017; 17(1):499. PMC: 5701353. DOI: 10.1186/s12906-017-2004-9. View

5.
Li Q, Wu F, Wen M, Yanagita T, Xue C, Zhang T . The Protective Effect of Antarctic Krill Oil on Cognitive Function by Inhibiting Oxidative Stress in the Brain of Senescence-Accelerated Prone Mouse Strain 8 (SAMP8) Mice. J Food Sci. 2018; 83(2):543-551. DOI: 10.1111/1750-3841.14044. View